(Q68872320)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516681%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Serum fungistatic and fungicidal activity in volunteers receiving antifungal agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516681%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

F Meunier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516681%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 February 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516681%20AND%20SRC:MED&resulttype=core&format=json

European journal of clinical microbiology

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516681%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516681%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516681%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

103-109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516681%20AND%20SRC:MED&resulttype=core&format=json

Ketoconazole for Treatment of Disseminated Coccidioidomycosis

28 September 2019

cites work

1 reference

12 December 2020

Impairing effect of food on ketoconazole absorption

1 reference

12 December 2020

Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients

1 reference

12 December 2020

Laboratory and clinical assessment of ketoconazole in deep-seated mycoses

1 reference

12 December 2020

The influence of gastric acidity on the bio-availability of ketoconazole

1 reference

12 December 2020

Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).

1 reference

12 December 2020

Disposition of ketoconazole, an oral antifungal, in humans

1 reference

12 December 2020

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality

1 reference

12 December 2020

Activity of amphotericin B, 5-fluorocytosine, and rifampin against six clinical isolates of Aspergillus

1 reference

12 December 2020

The influence of rifampin on quinidine and digoxin

1 reference

12 December 2020

Combination amphotericin B-rifampin therapy for pulmonary aspergillosis in a leukemic patient

1 reference

12 December 2020

Interaction of Ketoconazole with Rifampin and Isoniazid

1 reference

12 December 2020

Rifampin drug interactions

1 reference

12 December 2020

Interaction of rifampin and digitoxin

1 reference

12 December 2020

Synergistic Action of Amphotericin Band Rifampin against Candida Species

1 reference

12 December 2020

Pharmacokinetics of ketoconazole in normal subjects

1 reference

12 December 2020

Successful Treatment of Invasive Pulmonary Aspergillosis in the Immunocompromised Host

1 reference

12 December 2020

Pharmacokinetics of ketoconazole in patients with neoplastic diseases

1 reference

12 December 2020

Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy

1 reference

12 December 2020

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

12 December 2020

Effect of Amphotericin B and Rifampin Against Coccidioides immitis In Vitro and In Vivo

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02013478

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3516681%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference